Section Navigation
Section Navigation
- Module 4 Overview
Co-Occurring Conditions - 0%Lesson 1
Latent Tuberculosis InfectionActivities - 0%Lesson 2
Opportunistic Infections: PreventionActivities - 0%Lesson 3
Opportunistic Infections: TreatmentActivities - 0%Lesson 4
Sexually Transmitted InfectionsActivities - 0%Lesson 5
Hepatitis B CoinfectionActivities - 0%Lesson 6
Hepatitis C CoinfectionActivities
Lesson 6. Hepatitis C Coinfection
Learning Objective Performance Indicators
- Explain recommendations for HCV screening in people with HIV
- Describe the appropriate HCV testing algorithm
- Summarize the eligibility criteria and current guidelines for the simplified HCV treatment in people with HIV
- Discuss simplified HCV treatment regimens options for people with HIV
- List indications and methods for hepatocellular carcinoma surveillance in persons with chronic HCV and HIV
About this Lesson
Learning Objective Performance Indicators
- Explain recommendations for HCV screening in people with HIV
- Describe the appropriate HCV testing algorithm
- Summarize the eligibility criteria and current guidelines for the simplified HCV treatment in people with HIV
- Discuss simplified HCV treatment regimens options for people with HIV
- List indications and methods for hepatocellular carcinoma surveillance in persons with chronic HCV and HIV
Activities in this Lesson
- Quick ReferenceHepatitis C Coinfection Core Concepts
- Background and Epidemiology
- Natural History of HIV-HCV Coinfection
- Screening for HCV Infection
- HCV Diagnostic Testing
- Evaluation of Persons Diagnosed with HCV Coinfection
- Treatment of HIV in Persons with HCV Coinfection
- Treatment of HCV in Persons with HIV Coinfection
- Monitoring and Management of Chronic Liver Disease
- Special Considerations During Pregnancy
- Summary Points
Check
-On-
Learning
Questions
-On-
Learning
Questions
The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.